Could your pain be related to Rheumatoid Arthritis?

Learn about the signs and symptoms of Rheumatoid Arthritis and the options available for treatment.

Learn More

Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web’s most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Get Started

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Remember to take your pills with the Pill Reminder App?

Get pill and script reminders on your iPhone. Flexible scheduling options plus additional information on drug usage, side effects, interactions and more.

Learn More

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Welcome to Drugs.com

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Find helpful tools, wallet size personal medication records, mobile applications and more.

Featured Services
A to Z Drug List
Drugs by Condition
Pill Identifier
Drug Side Effects
Drug Dosage
Interactions Checker
News & Articles
FDA Drug Alerts
New Drug Approvals
New Drug Applications
Drug Imprint Codes
International Drugs
Drugs by Category
Pregnancy Warnings
Inactive Ingredients
Video Center
 Medical Conferences
Health Guides
Symptom Checker
FDA Consumer Updates Medication Record
Clinical Trial Results
Medical Encyclopedia
Medical Dictionary
Patient Care Notes
For Professionals
Generic Drugs
Veterinary Drugs
Popular Articles
Pill Identifier App (itunes)
Pill Reminder App (itunes)
Info en Español
Top 100 Drugs
Top 200 by sales
Abilify
Accutane
Actiq
Actonel
Adderall
Adipex
Advair
Allegra
Alli
Ambien
Amitiza
Aricept
Avandia
Avodart
Boniva
Botox
Byetta
Caduet
Celebrex
Celexa
Chantix
Cialis
Ciprofloxacin
Claritin
Clomid
Coumadin
Crestor
cyclobenzaprine
Cymbalta
Dilaudid
Diovan
Effexor
Enbrel
ephedrine
Femara
fish oil
Flomax
folic acid
Fosamax
gabapentin
Gardasil
Geodon
 Hoodia
Humira
hydrocodone
Insulin
Keppra
Lamictal
Lasix
Levaquin
Levitra
Lexapro
Lipitor
lisinopril
lithium
Lotrel
Lunesta
Lyrica
Melatonin
metformin
methadone
methotrexate
Mirapex
Mirena
Namenda
naproxen
Nasonex
Neurontin
Nexium
Nizoral
Norco
Norvasc
omeprazole
Ortho Evra
oseltamivir
oxycodone
oxycontin
Paxil
Paracetamol
Percocet
phentermine
Plan B
Plavix
prednisone
 Prevacid
Prilosec
promethazine
Propecia
Protonix
Provigil
Prozac
Pulmicort
Rogaine
Seroquel
sertraline
simvastatin
Singulair
Soma
Spiriva
Suboxone
Synvisc
Tamiflu
tamoxifen
Taxol
testosterone
thyroid
Topamax
tramadol
trazodone
Tylenol
Ultram
Valtrex
Viagra
Vicodin
Vioxx
Voltaren
Vytorin
Wellbutrin
Xanax
Xenical
Yasmin
Zetia
Zocor
Zoloft
Zyprexa
Zyrtec
More A-K · More L-Z · By Class · UK Medicines
For Consumers For Professionals For Researchers Announcements
Latest FDA New Drug Approvals

Pertzye
Pertzye (pancrelipase) is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine ...

Fabior
Fabior (tazarotene) Foam is a retinoid indicated for the topical treatment of acne vulgaris.

Dymista
Dymista (azelastine and fluticasone) nasal spray is an H1-receptor antagonist and corticosteroid combination indicated for the relief of ...

More...

Drugs in Development – Not yet approved

cobicistat, elvitegravir, emtricitabine and tenofovir
The Quad (cobicistat, elvitegravir, emtricitabine and tenofovir) is a once-daily, single-tablet combination containing an integrase ...

Lorqess
Lorqess (lorcaserin) is a selective serotonin 2C receptor agonist in development for weight management, including weight loss and ...

tofacitinib
Tofacitinib is an investigational, oral JAK inhibitor being studied for the treatment of adult patients with moderately to severely active ...

More...

Daily Medical News

RSS
FDA Panel Votes Against New Use for Blood Thinner Xarelto
WEDNESDAY, May 23 -- An advisory panel to the U.S. Food and Drug Administration on Wednesday voted against a new use of a new blood thinner, Xarelto, to cut the risk of potentially lethal clots in people with acute coronary syndrome. The panel of experts voted 6-to-4, with one member abstaining, against using the drug in these high-risk patients. Panel members said there wasn't enough data in...
Calcium Supplements May Be Bad for Your Heart: Study
WEDNESDAY, May 23 -- Many older Americans take calcium supplements to prevent bone loss, but they may be significantly increasing their risk for a heart attack, a new study suggests. These supplements do not help prevent heart attacks or stroke as some previous research has suggested, the study authors say. But dietary calcium might reduce the risk, they noted. "While a moderately high intake...
IUDs, Implants Best for Long-Term Birth Control: Study
WEDNESDAY, May 23 -- New research suggests that long-term birth control options, such as intrauterine devices (IUDs) and under-the-skin implants, are 20 times more effective for preventing pregnancy than short-term contraceptives, such as birth control pills, patches and rings. "IUDs and implants are very effective; they rival tubal ligation in terms of preventing pregnancy," said study...

More...

Latest Pharma Industry News

RSS
Digestive Care, Inc. Announces FDA Approval of Pertzye (pancrelipase) Delayed-Release Capsules
BETHLEHEM, Pa., May 18, 2012 /PRNewswire/ -- Digestive Care, Inc. (DCI), announced that the company has received U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for Pertzye, indicated for the treatment of Exocrine Pancreatic Insufficiency (EPI) due to cystic fibrosis (CF) or other conditions. Pertzye is a unique pancreatic enzyme product...
MDLinx Survey: Ninety Percent of US Oncologists Report Crucial Cancer Drug Shortage
Physicians express concern about safety of emergency overseas drugs approved by FDA WASHINGTON--(BUSINESS WIRE)--May 23, 2012 - In an MDLinx (www.mdlinx.com) survey conducted of 200 U.S. oncologists this month, 90.5 percent reported experiencing shortages of key cancer drugs in their practices. MDLinx, a web property of M3 USA (http://usa.m3.com) is the nation's leading specialty physician...
U.S. Marshals Seize Unapproved New Drug From Crescendo Therapeutics LLC
California firm previously warned not to market HybriSil topical corticosteroid U.S. Marshals, acting at the request of the Food and Drug Administration, have seized HybriSil (methylprednisolone acetate 1% percent in silicone gel), an unapproved new drug marketed by Crescendo Therapeutics, LLC, of Vista, Calif. The seizure, which took place under a warrant issued by the U.S. District Court...

More...

Latest Additions to Drugs.com

Recently added consumer and prescribing information: Pertzye, Fabior, Elelyso, Dymista, Stendra, Amyvid, Binosto, QNASL, Omontys, Surfaxin ...also see new filings.
Introducing the new Drugs.com Pill Reminder App for iPhone and iPod Touch
Drugs.com is proud to announce the release of a flexible and easy-to-use Pill Reminder and Personal Medication Record (PMR) app for your iPhone or iPod touch. Use this application to manage any combination of medications, vitamins/supplements and birth control pills. The intuitive interface lets you build a list of medications and setup reminders with ease ...
Drugs.com Pill Identifier Lite mobile app is now the #1 paid medical application in the Apple app store
We are pleased to announce the Pill Identifier Lite mobile application has become the #1 paid medical app in the U.S. Apple App store. Thanks to all those who have downloaded the app. We look forward to providing regular updates and improvements. Please check out our apps page to get more information on our growing ...
Pill Identifier Update
We have updated the pill identifier tool to help identify imprints that have been entered upside down and with similar letters. For example the imprint for Divalproex Sodium Extended-Release is 691: This could be read as 169 if the pill was held upside down. The pill identifier now recognizes imprints like this and will suggest ...
See more blog posts or follow us on twitter.

(web4)